AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more
A dividend of $1.64 per share will be paid with a record date of May 15, 2025, and an ex-dividend date of April 15, 2025. The last dividend of $1.64 was paid on February 14. Read more...